Bio-Gate AG (XTER:BIG1) Asset Impairment Charge : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Asset Impairment Charge?

Bio-Gate AG's Asset Impairment Charge for the six months ended in Dec. 2023 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Bio-Gate AG Asset Impairment Charge Historical Data

The historical data trend for Bio-Gate AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Asset Impairment Charge Chart

Bio-Gate AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Bio-Gate AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Bio-Gate AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Bio-Gate AG Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Gate AG (XTER:BIG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

BIG1:Germany BIG1:Germany

Address

Neumeyerstraße 28-34, Nürnberg, DEU

Website

http://www.biogate.de

Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.

Executives

Karl Richter

Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines